Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus.

Kaina ChenWei Kwan SngJoanne Hui-Min QuahJin LiuBee Yen ChongHwee Khim LeeXue Fei WangNgiap Chuan TanPik-Eu ChangHong Chang TanYong Mong BeeGeorge Boon Bee Goh

Published in: PloS one (2020)

Our study demonstrated a considerably high prevalence of NAFLD among T2DM patients, with the proportion of advanced liver fibrosis among T2DM NAFLD patients much higher than the general population. Given that NAFLD is largely asymptomatic, increased awareness and vigilance for identifying NAFLD and increased liver stiffness among T2DM patients should be advocated.

Keyphrases

end stage renal disease
liver fibrosis
newly diagnosed
ejection fraction
chronic kidney disease
type diabetes
patient reported outcomes
glycemic control
weight loss
adipose tissue